Regeneron Pharmaceuticals Inc (REGN)

Profitability ratios

	Sep 30, 2025	Jun 30, 2025	Mar 31, 2025	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020
Gross profit margin	85.39%	85.57%	85.79%	86.13%	85.31%	84.54%	83.87%	82.95%	83.86%	84.35%	85.08%	85.48%	83.09%	82.89%	82.87%	83.05%	84.63%	84.75%	84.15%	84.04%
Operating profit margin	25.89%	27.02%	27.20%	28.10%	29.26%	30.27%	30.76%	32.64%	34.71%	35.98%	39.20%	42.16%	47.10%	49.77%	55.25%	55.67%	55.19%	53.94%	43.37%	42.09%
Pretax margin	36.11%	34.30%	35.38%	33.66%	35.89%	34.01%	30.85%	32.01%	33.41%	37.69%	37.64%	39.91%	44.04%	44.59%	55.33%	58.03%	59.42%	58.37%	47.78%	44.84%
Net profit margin	32.13%	31.37%	31.94%	31.07%	33.61%	32.04%	29.45%	30.14%	30.47%	33.93%	33.81%	35.64%	39.17%	39.97%	48.06%	50.25%	51.65%	50.11%	43.53%	41.35%

	Sep 30, 2025	Jun 30, 2025	Mar 31, 2025	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020
Operating return on assets (Operating ROA)	9.18%	10.05%	10.20%	10.57%	10.82%	11.31%	11.72%	12.94%	14.13%	14.87%	16.13%	17.57%	23.33%	26.03%	34.62%	35.18%	31.57%	31.09%	22.45%	20.84%
Return on assets (ROA)	11.40%	11.67%	11.98%	11.69%	12.43%	11.98%	11.22%	11.95%	12.41%	14.02%	13.91%	14.85%	19.40%	20.90%	30.11%	31.75%	29.55%	28.88%	22.53%	20.47%
Return on total capital	16.76%	16.40%	17.12%	16.47%	17.16%	16.50%	15.24%	16.45%	17.86%	20.17%	20.09%	21.70%	28.42%	30.93%	46.15%	49.99%	46.96%	48.25%	37.24%	35.08%
Return on equity (ROE)	14.79%	14.89%	15.31%	15.03%	15.87%	15.32%	14.29%	15.22%	16.03%	17.90%	17.80%	19.14%	25.05%	27.49%	39.84%	43.03%	40.53%	41.02%	33.43%	31.86%